EU directive on bovine spongiform encephalopathy will not affect drugsBMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7107.551a (Published 30 August 1997) Cite this as: BMJ 1997;315:551
- David R B Bowser, Sales and marketing directora
- a CP Pharmaceuticals Ltd, Wrexham LL13 9UF
Editor—In his letter Alan Earl-Slater states that if certain European proposals go ahead then, with effect from 31 December 1997, certain categories of drugs will not be allowed on the market in the European Union.1 He goes on to name two of my company's products, Hyalase and Hypurin (insulin). This is not the case. Both products will …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial